Product: Alcon’s “No Reason to Wait: Success Starts Now” program.
Top Line: Alcon’s new program aims to help ECPs realize the earning potential of treating MGD in their practices. The program focuses on helping practices rebound by meeting needs of those with dry eye.
Close Up: Alcon’s new program launch with a variety of resources for optometrists and ophthalmologists interested in adopting the Systane iLux Suite to generate cash flow with elective procedures including:
- The Systane iLux system: iLux is a portable technology that delivers a MGD treatment in just 8 to 12 minutes and allows personalized treatment based on patient needs.
- DEEPTM (Dry Eye Excellence Program): This end-to-end implementation program helps ECPs reach practice goals. Practices participating in the DEEP program generate 2 to 3 times the procedure volume compared to accounts not utilizing the program.
- Systane MyEyes Program: The first-and-only patient retention program in the MGD space to help drive increased retention, continuity of care and procedure volume.
- And a series of web events focused on everything from virtual demos and practice protocols to sessions with leading dry eye thought leaders discussing the most common implementation barriers and forthcoming learning modules on Alcon Experience Academy.
Vital Stats: Alcon recently received clearance from the FDA to market its new Systane iLux2 system, which will combine: high-resolution digital visualization, recording and media storage; a built-in near infrared meibography camera; and, white light surface imaging into a single, handheld, portable device. Practitioners who join the “No Reason to Wait” program by purchasing a Systane iLux will have exclusive access to upgrade to the Systane iLux2 at preferred pricing once it becomes available in late 2021. Interested ECPs can visit SystaneiLux.com, contact their Alcon sales representative or email iLux@alcon.com.
www.alcon.com